Clinical Trials Logo

Hypoxemia clinical trials

View clinical trials related to Hypoxemia.

Filter by:

NCT ID: NCT04410757 Completed - Hypotension Clinical Trials

Point of Care Ultrasound Evaluation in the Post-Anesthesia Unit

Start date: August 1, 2018
Phase:
Study type: Observational

The purpose of this observational research study is to examine how point-of care ultrasound affects the workup and management of perioperative complications for specific clinical scenarios of low blood pressure (hypotension), low blood oxygen (hypoxemia), in the post- anesthesia care unit (PACU).

NCT ID: NCT04398290 Withdrawn - COVID-19 Clinical Trials

iNOPulse for COVID-19

NO-COVER
Start date: December 1, 2020
Phase: Phase 2
Study type: Interventional

This randomized, controlled trial will assess the efficacy and safety of pulsed iNO in subjects with COVID-19 who are hospitalized and require supplemental oxygen.

NCT ID: NCT04383821 Completed - Hypoxemia Clinical Trials

Comparison of the Non-rebreather Mask With the Double-trunk Mask

Start date: May 15, 2020
Phase: N/A
Study type: Interventional

This study will compare the impact of the Double-Trunk Mask (DTM) with the Non-Rebreather Mask (NRM) on the blood gases of patients with severe hypoxemia.

NCT ID: NCT04346693 Completed - Pneumonia Clinical Trials

An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19

Start date: April 8, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate an effectiveness of the drug Dalargin in combination with Leitragin for the prevention and treatment of severe pulmonary complications symptoms associated with severe and critical coronavirus infection cases (SARS COVID19, expanded as Severe acute respiratory syndrome Cоrona Virus Disease 2019 ). Test drugs that will be administered to patients are: - Leitragin, solution for inhalation administration, - Dalargin, solution for intravenous and intramuscular administration.

NCT ID: NCT04346420 Completed - COVID Clinical Trials

Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19

Start date: April 9, 2020
Phase: N/A
Study type: Interventional

This study will investigate the impact of the Double-Trunk Mask (DTM) on the reduction of oxygen titration in patients with severe hypoxemia.

NCT ID: NCT04241861 Completed - Respiratory Failure Clinical Trials

High-flow Nasal Cannula vs. Helmet PSV vs. Helmet CPAP During Respiratory Failure

HIGHFLOWHELMET
Start date: January 22, 2020
Phase: N/A
Study type: Interventional

The investigators designed a cross-over, randomized trial to assess the physiological effects of helmet pressure support ventilation (PSV) and continuous positive airway pressure (CPAP) as compared to high-flow nasal cannula during the early phase of acute hypoxemic respiratory failure

NCT ID: NCT04238351 Not yet recruiting - Hypoxemia Clinical Trials

Transnasal Humidified Rapid Insufflation System for Intubation

Start date: February 25, 2020
Phase: N/A
Study type: Interventional

Transnasal humidified rapid insufflation ventilator exchange (THRIVE) or not during the anesthesia induction

NCT ID: NCT04193878 Recruiting - Pneumonia Clinical Trials

ARrest RESpiraTory Failure From PNEUMONIA

ARREST
Start date: June 1, 2020
Phase: Phase 3
Study type: Interventional

This research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.

NCT ID: NCT04170062 Recruiting - Clinical trials for Pulmonary Disease, Chronic Obstructive

Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest

Start date: December 15, 2020
Phase: N/A
Study type: Interventional

This study is meant to compare the amount of oxygen required for hypoxemia relief between current standard of care (oxygen only) and oxygen with the addition of high flow air for Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and Pulmonary Hypertension (PH) patients during rest. Subjects will be titrated from 0 L/min until they maintain 95% SpO2 for each of the following delivery methods: 1. Pulses of pure oxygen (control) 2. Constant high flow air with pulses of pure oxygen 3. Out of phase pulses of high flow air and pure oxygen

NCT ID: NCT04159116 Completed - Hypoxemia Clinical Trials

Prevention and Treatment of Laryngospasm and Hypoxemia Based on Risk Factors in Adult Outpatients Undergoing EGD

Start date: November 4, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to identify patient and provider-chosen factors that put patients at risk for the development of hypoxemia (oxygen saturation < 90% for 5 seconds) during endoscopy and to use this knowledge to develop a treatment protocol for specific causes of hypoxemia in adult esophagogastroduodenoscopy outpatients.